CRA consultants supported a pharmaceutical company in its successful challenge of an ANDA filed by a generic manufacturer. The generic company sought to manufacture and sell generic versions of two related diabetes treatments. CRA provided a report analyzing evidence of commercial success for the branded pharmaceutical products as well as deposition and trial testimony.
CRA expands its Intellectual Property Practice
CRA has expanded its Intellectual Property Practice with the addition of 20 consultants including Chris Bakewell and Julia Rowe, who have joined the firm as...